We are excited to announce the official launch of the Spectra module, which enhances our oncology analytics portfolio. This new module features the capability to profile somatic variants from paired tumor and germline VCF files. Within minutes, it can accurately detect somatic variants as low as 5% frequency. Additionally, Spectra integrates a comprehensive somatic variant database and a robust pharmacogenomic solution for thorough tumor profiling. Spectra has been seamlessly integrated with GenomeArc Horizon, allowing you to gain multi-omics insights into tumor variants. More on GenomeArc Horizon: https://lnkd.in/dFdgNzXS Request a demo: https://lnkd.in/dQpCct4V #multiomics #cancer #tumor #genomics
GenomeArc’s Post
More Relevant Posts
-
Meet our Founder, Dr. Mohammed Uddin Dafil, a neurogeneticist and a visionary who started GenomeArc's journey to implement genomic medicine to create global impact. He did his post-graduate degree in artificial intelligence, PhD in human genetics and postdoc at The Hospital for Sick Children in rare neurodevelopmental disorders. He is a renowned scientist, and an academic fuelled by entrepreneurial spirit. He established GenomeArc in Canada 🇨🇦 to accelerate the implementation of genomic medicine, leveraging cutting-edge computation and algorithm development to provide precise and ultra-fast diagnoses/therapeutic insights for patients with rare diseases and cancer. #Scientist #medicine #SickKids Dubai Health #rarediseases #genomics #futuretech
-
-
We are delighted to announce our guest speaker for GenomeArc’s clinical genomics webinar. We are back this July with a topic you requested, a combination of Cancer Genomics and Bioinformatics Techniques! On July 11th we will have Deniz Duzenli from Humber College. She will be discussing her research in Pan-cancer genomics through a bioinformatics approach. Deniz has also joined us recently for her internship and we are thrilled to have her with us this July. Register here: https://lnkd.in/d7kvbrbY #webinar #clinicalgenomics #genomics #GenomeArc
This content isn’t available here
Access this content and more in the LinkedIn app
-
🌟 CHEK2 variants are now implicated in multiple malignancies in various tissues. Numerous independent studies reported CHEK2 gene association with a spectrum of malignancies. 🌟 The most common malignancies are breast cancer, colon and thyroid. 🌟 CHEK2 was specifically screened for breast cancer, may miss out other malignancies. 🌟 c.1100delC is one of the most frequent risk site that requires additional testing. CHEK2 Papers: https://lnkd.in/d8f7VPke https://lnkd.in/dS3_HUnv https://lnkd.in/dzxhacy6 #CHEK2 #cancer #genetics #tumor #genomics
-
-
🌟 This year, GenomeArc's multinational team, actively engaged with YOU, the global clinical genomics community, through meetings and public engagement. Our aim is to help our users for years to come with your genomic analytics. 🌟 We want to create impact by providing ultra-fast clinical genomic solutions to YOU enabling fast diagnosis and personalized therapeutics. 🌟 Diversity is our strength, our multinational team are passionate about democratizing genomic analytics worldwide. 🌟 From University of Toronto to Dubai Health to NeuroGen Healthcare, we went through continents to meet YOU and to empower your genomic abilities. #genomics #genomeArc #Team #genetics #genomesequencing
-
-
✨ Step into the next era of genomic analysis with GenomeArc Horizon. Combining exceptional accuracy with ultra-fast processing (>5 million variants in 10 minutes). ✨ This innovative software accelerates tertiary genome analysis for rare diseases and cancer. Experience the fusion of speed and precision with GenomeArc Horizon, the ultimate tool for modern genomics. ✨ More about GenomeArc Horizon: https://lnkd.in/dFdgNzXS ✨ Press release on analysis acceleration: https://lnkd.in/dQccMce6 #Genomics #RareDiseases #CancerResearch #GenomeArcHorizon #PrecisionMedicine